Assyro AI

FDA Orange Book · active-ingredient family

Mestranol; norethindrone

Mestranol; norethindrone is approved as 7 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:NORINYL 1+50 28-DAY · NDA 016659

7

Brand (NDA)

4

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
NORINYL 1+50 28-DAYRLDACTAVIS LABS UT INCNDA 016659Approved Prior to Jan 1, 1982
NORINYL×2ACTAVIS LABS UT INCNDA 013625Approved Prior to Jan 1, 1982
NORINYL 1+80 21-DAYGD SEARLE LLCNDA 016724Approved Prior to Jan 1, 1982
ORTHO-NOVUM 1/50 21×3ORTHO MCNEIL PHARMNDA 012728Approved Prior to Jan 1, 1982
ORTHO-NOVUM 1/80 21×2ORTHO MCNEIL PHARMNDA 016715Approved Prior to Jan 1, 1982
NORINYL 1+80 28-DAYGD SEARLE LLCNDA 016725Approved Prior to Jan 1, 1982
ORTHO-NOVUM 1/50 28ORTHO MCNEIL JANSSENNDA 016709Approved Prior to Jan 1, 1982

Generic (ANDA) products (4)

ProductApplicantApplicationTEApproved
NORETHINDRONE AND MESTRANOLWATSON LABSANDA 070758Jul 01, 1988
NORETHINDRONE AND MESTRANOLWATSON LABSANDA 070759Jul 01, 1988
NORETHIN 1/50M-21HERITAGE PHARMAANDA 071539Apr 12, 1988
NORETHIN 1/50M-28HERITAGE PHARMAANDA 071540Apr 12, 1988

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Mestranol; norethindrone — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.